Ian Egle

This inventor holds 16 USPTO granted patents and 3 published patent applications and 2 EPO patents. Top assignees: Astrazeneca Ab, Nps Allelix Corporation, Apotex Inc.. Active years: 1999-2013.

USPTO Granted Patents = 16 (Patent Applications = 3)

% Patents Active = 12.5

EPO Patents = 2 (Patent Applications = 4)

Average Co-Inventor Count = 6.0

ph-index = 4

Forward Citations = 125(Granted Patents)

Location History:

Mississauga, CA (1999 - 2003)
Georgetown, CA (2010)
Toronto, CA (2006 - 2011)
North York, CA (2009 - 2013)
Ontario, CA (2013)

Company Filing History:

Nps Allelix Corporation

Nps Pharmaceuticals, Inc.

patents

5. 1 out of 834,411

Other

patents

where one patent can have more than one assignee

Years Active: 1999-2013

Loading Chart...

16 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 8377940 - Oxadiazole derivatives and their use as metabotropic glutamate receptor potentiators—842 (2013-02-19),

2. 8377939 - Oxadiazole derivatives and their use as metabotropic glutamate receptor potentiators 842 (2013-02-19),

3. 8153638 - Metabotropic glutamate-receptor-potentiating isoindolones (2012-04-10),

4. 7968570 - Isoindolone compounds and their use as metabotropic glutamate receptor potentiators (2011-06-28),

5. 7868008 - Substituted isoindolones and their use as metabotropic glutamate receptor potentiators (2011-01-11),

6. 7816354 - Oxazolidinone compounds and their use as metabotropic glutamate receptor potentiators (2010-10-19),

7. 7807706 - Metabotropic glutamate-receptor-potentiating isoindolones (2010-10-05),

8. 7799792 - Metabotropic glutamate receptor oxadiazole ligands and their use as potentiators 841 (2010-09-21),

9. 7790717 - Spiro-oxazolidinone compounds and their use as metabotropic glutamate receptor potentiators (2010-09-07),

10. 7485722 - Spiro-oxazolidinone compounds and their use as metabotropic glutamate receptor potentiators (2009-02-03),

11. 7112595 - Heteropolycyclic compounds and their use as metabotropic glutamate receptor antagonists (2006-09-26),

12. 6667336 - GlyT-1 inhibitors (2003-12-23),

13. 6579987 - Diaryl-enynes (2003-06-17),

14. 6525085 - Diaryl-enynes (2003-02-25),

15. 6426364 - Diaryl-enynes (2002-07-30),

Title: Inventor Ian Egle - Pioneering Innovations in North York, CA

Introduction: Ian Egle is a visionary inventor based in North York, Canada, known for his groundbreaking contributions to the field of technology and engineering.

Latest Patents: Ian Egle holds several patents in the areas of renewable energy, sustainable transportation, and smart home technologies, showcasing his commitment to creating a more efficient and eco-friendly world.

Career Highlights: With a career spanning over two decades, Ian Egle has worked with leading research institutions and tech companies to bring his innovative ideas to life. His passion for pushing the boundaries of technology has led to the development of cutting-edge solutions that have revolutionized various industries.

Collaborations: Ian Egle has collaborated with top engineers, scientists, and designers from around the globe, fostering a culture of creativity and excellence in all his projects. His ability to work seamlessly in multidisciplinary teams has been instrumental in the success of his inventions.

Conclusion: Ian Egle's relentless pursuit of innovation and his dedication to creating a sustainable future make him a true pioneer in the world of technology. His work continues to inspire the next generation of inventors and engineers to push the limits of what is possible.